论文部分内容阅读
目的对甘精胰岛素与瑞格列奈治疗2型糖尿病临床效果进行分析与探讨。方法资料选自2013年3月—2014年3月在该院接受治疗的2型糖尿病病人72例,随机分为对照组和实验组,每组各36例。给予对照组病人行常规治疗,实验组病人则行甘精胰岛素与瑞格列奈治疗,对比分析两组病人的临床效果。结果经治疗之后,两组病人的临床症状均得以有效改善,且实验组病人的临床疗效明显优于对照组,两组间比较差异存在统计学意义(P<0.05)。结论针对2型糖尿病,予以甘精胰岛素与瑞格列奈治疗,不仅能提升其治疗效果,对于提升其整体生活质量也具有重要意义,具有显著的意义,值得临床推广使用。
Objective To analyze and discuss the clinical effects of insulin glargine and repaglinide on type 2 diabetes mellitus. Method data were selected from 72 patients with type 2 diabetes who were treated in the hospital from March 2013 to March 2014 and were randomly divided into control group and experimental group with 36 cases in each group. Patients in the control group were treated routinely. Patients in the experimental group received glargine and repaglinide, and the clinical effects of the two groups were compared. Results After treatment, the clinical symptoms of both groups were effectively improved, and the clinical efficacy of the experimental group was significantly better than that of the control group. The difference between the two groups was statistically significant (P <0.05). Conclusions For type 2 diabetes, insulin glargine and repaglinide treatment can not only improve the therapeutic effect, but also have great significance for improving the overall quality of life. It is of great significance and worthy of clinical promotion.